Blog
RSS FeedPosted by Michael Wonder on 10 May 2020
COVID-19: Health Minister David Clark announces more medicines, vaccines in $160 million PHARMAC budget boost
10 May 2020 - Health Minister David Clark has rejected claims he and other Government ministers have been "gagged", as ...
Posted by Michael Wonder on 26 Apr 2020
PHARMAC says it will need more funding amid global COVID-19 crisis
26 April 2020 - The Government's drug-funding agency says it will need more money as the global impact of COVID-19 ...
Posted by Michael Wonder on 23 Apr 2020
Recent PHARMAC funding decisions
22 April 2020 - You may have read about PHARMAC’S decision this week to scrap a lung cancer drug funding ...
Posted by Michael Wonder on 22 Apr 2020
UK underinvested in health care, says pharma boss
22 April 2020 - The UK has underinvested in health care "over many years" which has hampered its ability to ...
Posted by Michael Wonder on 17 Apr 2020
COVID-19: Government funds $276m for PPE, PHARMAC and residential aged care
18 April 2020 - The Government will spend almost $300m of its COVID-19 relief fund to buy more PPE, fund medicines ...
Posted by Michael Wonder on 06 Apr 2020
COVID-19: suggestions for funding changes
6 April 2020 - PHARMAC is receiving suggestions from many stakeholders about funding changes we could make to support the health ...
Posted by Michael Wonder on 02 Apr 2020
Proposal to fund modified release pancreatic enzyme granules (Creon Micro)
2 April 2020 - PHARMAC is seeking feedback on a proposal to fund a new modified-release granule formulation of pancreatic ...
Posted by Michael Wonder on 20 Mar 2020
Decision to decline inactive medicines funding applications
20 March 2020 - To give people more clarity about what medicines PHARMAC is, or is not, actively considering for ...
Posted by Michael Wonder on 26 Feb 2020
Decision to fund ivacaftor (Kalydeco) for people with cystic fibrosis with the G551D mutation
26 February 2020 - PHARMAC is pleased to announce a decision to fund ivacaftor (Kalydeco) for the treatment of people ...
Posted by Michael Wonder on 12 Feb 2020
Decision for funding in the blood, alimentary and immunosuppressant therapy areas
12 February 2020 - PHARMAC is pleased to announce a decision to approve proposals relating to medicines in the blood, ...
Posted by Michael Wonder on 12 Feb 2020
Quebec, New Brunswick, Newfoundland, Nova Scotia and Manitoba join Alberta, Saskatchewan, in adding Knight’s Probuphine to their provincial drug plans in the fight against the opioid crisis
11 February 2020 - Probuphine is also listed for reimbursement through the Non-Insured Health Benefit (NIHB) and Veteran Affairs Canada drug ...
Posted by Michael Wonder on 03 Feb 2020
Man's friends start NZ billboard campaign to raise funds for his cancer treatment
3 February 2020 - Friends of a cancer patient have rallied to rent billboards in Auckland to help fundraise for a ...
Posted by Michael Wonder on 24 Jan 2020
PHARMAC seeking views on new cystic fibrosis medicine
24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) ...
Posted by Michael Wonder on 22 Jan 2020
Parents demanding PHARMAC funding boost unleash on politicians at Parliament steps
22 January 2020 - The parents of a daughter with cystic fibrosis have cycled 1300 km from Dunedin to Wellington ...
Posted by Michael Wonder on 15 Jan 2020
PHARMAC considering new medicines for type 2 diabetes mellitus
15 January 2020 - PHARMAC is seeking proposals from pharmaceutical suppliers for new medicines that could help New Zealanders living ...